Investor FAQs

 

January 1, 2015.

Each share of RFMD common stock was converted into the right to receive 0.2500 (the "RFMD Exchange Ratio") of a share of Qorvo common stock. RFMD shareholders did not receive any fractional shares of Qorvo common stock in the merger. Instead of receiving any fractional shares, each holder of RFMD common stock was paid an amount in cash, without interest, rounded to the nearest cent, determined by (a) dividing that fraction by the RFMD Exchange Ratio and (b) multiplying the result by the average closing price of a share of RFMD common stock on NASDAQ for the 10 most recent trading days that the RFMD common stock had traded, ending on the trading day one day prior to the closing date.

Each share of TriQuint common stock was converted into the right to receive 0.4187 (the "TriQuint Exchange Ratio") of a share of Qorvo common stock. TriQuint stockholders did not receive any fractional shares of Qorvo common stock in the merger. Instead of receiving any fractional shares, each holder of TriQuint common stock was paid an amount in cash, without interest, rounded to the nearest cent, determined by (a) dividing that fraction by the TriQuint Exchange Ratio and (b) multiplying the result by the average closing price of a share of TriQuint common stock on NASDAQ for the 10 most recent trading days that the TriQuint common stock had traded, ending on the trading day one day prior to the closing date.

The merger is intended to qualify as a tax-free reorganization. Additional information about tax consequences related to the merger can be found beginning on page 131 of the joint proxy statement/prospectus filed with the SEC on July 31, 2014 and linked here.

We urge all holders to consult with their tax advisors as to the tax consequences of the mergers in their particular circumstances, including the applicability and effect of the alternative minimum tax and any state, local, foreign or other tax laws.

Qorvo is listed on NASDAQ under symbol QRVO.

Please see our Events Calendar for all upcoming releases.

Qorvo's year-end will occur with the close of the March quarter.

Qorvo's transfer agent is American Stock Transfer & Trust Company, LLC and representatives can be contacted at (718) 921-8124.

The CUSIP number for Qorvo common stock is 74736K 101.

Qorvo does not have a direct stock purchase plan. Shares may be purchased through a broker of your choice.

Please submit your question using the form below.

* Indicates required field